I used a 'diff' [URL] here because ... it might be 'less' subject to [the risk of] '
Wikipedia:Link rot' than [would have been ... the case with] a link to [the "Talk:" page section]
which -- (in the course of time) -- might get 'archived' -- perhaps even leading to a
dead link (see "dead link") -- if [/when] ... some amount of time passes.
Done. :) I've gone through the entire
list of drugs to find INNs that redirect. Unless I've missed any (which is very possible) they should all be listed on this page. I will let a few days go by for people to raise any concerns then I will move those pages with no objections.
Matt 19:29, 24 Dec 2004 (UTC)
Source document for INNs
What is the primary source document for INNs ? I suggest that it is the WHO Chronicle. A link to an archive of relevant scanned PDF copies containing proposed and recommended INNs can be found at
http://www.who.int/druginformation/ --
Derek Ross |
Talk 16:39, 2004 Dec 30 (UTC)
List of names to fix
Here I'm compiling a list of drugs that aren't listed under their INN, because I know that the naming of pages can be a sensitive issue, I'm going to mention my intent on the talk page long before moving the page. I will direct people here for discussion if they object.
For the naturally occuring short polypeptides and proteins, when we have the "one gene-one polypeptide" rule, their names should be acording to the
NCBI site -
http://www.ncbi.nlm.nih.gov/mapview/map_search.cgi?taxid=9606,. While in those cases where a single gene codes the information for several polypeptide chains, as it is with POMK and
ACTH, or where the products of several different genes are necessary for the formation of the final functional protein, as it is with the GCB family and GCA, and their product
hCG, in these cases we should use their well known abbreviations.
That is a wrong move, cobalamin refers to a group of compounds, and
cyancobalamin is one of them, which by the way is an artefact produced during the purification proces of the naturally occuring forms. So, the redirection should go from cyancobalamin to cobalamins (or
Vitamin B12).
BorisTM13:15, 31 October 2005 (UTC)reply
This is a list of INNs that redirect to another page but moving has been objected to. Reasons for not moving the page should be included with each entry.
Since the drug is no longer widely in clinical use, and it's almost never referred to by its INN, I think methicillin should stay where it is. -
Techelf09:09, 26 January 2006 (UTC)reply
methylcobalamin is a redirect to a page about a different substance. They may be related, but one is not the parent of the other. I disagree with the redirect. Redirects inhibit contribution since as a new user I don't know how to fix it. --
Gearspring14:58, 24 January 2006 (UTC)reply
Disagree [to moving page]. Ximelagatran is the oral form, which happens to be biotransformed into melagatran.
JFW |
T@lk 22:14, 23 Dec 2004 (UTC)
Ah, then it's a case of a closely related drug that doesn't have it's own page yet. OK.
Matt 17:44, 24 Dec 2004 (UTC)
Ummm, melagatran actually redirects to ximelagatran, because melagatran is only for intravenous use and I don't expect it to be used very often.
JFW |
T@lk 18:01, 25 Dec 2004 (UTC)
DON'T do this - this article also contains material on physiological function of tPA. If you really feel the urge, you can create an article about rtPA (recombinant tissue plasminogen activator), but I wouldn't.
JFW |
T@lk 13:57, 22 Dec 2004 (UTC)
I'm sure that people wouldn't agree to it being moved, perhaps if there's more info on the medicinal uses of the substance, then the page can be split.
Matt 16:21, 22 Dec 2004 (UTC)
I wouldn't mind seeing it moved to dronabinol. People often confuse THC with
nabilone, when it is really dronabinol. As long as the first sentence of the lead mentions that dronabinol is THC, then it should avoid confusion.
Rad Racer 23:07, 30 Mar 2005 (UTC)
The article doesn't make it clear why the redirect and I don't know. Seeking further clarification.
Matt 18:16, 23 Dec 2004 (UTC)
If anything it should probably redirect to
progestogen, but would be better off being an actual article
Techelf 05:23, 24 Dec 2004 (UTC)
levonorgestrel now redirects to
progestin which is a more specific and accurate redirect. In the interest of abolishing INN redirects it could be converted into a stub by anyone who wants to do so, but I won't because I have nothing to contribute to such a stub other than the definition that levonorgestrel is a progestin.
Col.Kiwi 17:38, 18 Apr 2005 (UTC)
No, levothyroxine and liothyronine are different thyroid hormone analogues. They all need new pages.
Thyroid hormone is about the physiological substance.
JFW |
T@lk 18:01, 25 Dec 2004 (UTC)
This suggestion does not make sense to me. The mesylate part of the salt is not related to pharmacological action, it's just one of thousands of possible salts of this compound.
Cacycle 18:32, 23 Dec 2004 (UTC)
That's a good point, there are several drugs like this. In my list of INNs (from the US gov), this was listed as that particular salt and I don't know why. I just checked the ATC (
http://www.whocc.no/atcddd/) and it's just listed as imatinib so I'll change the name in the drug list. I sure wish I had a list of 'official' INNs though.
Matt 21:20, 23 Dec 2004 (UTC)
If "imatinib mesylate" is the INN, usually "imatinib" is listed as an INN Modified (INNM). Either way, I agree that it would be more appropriate to use the drug name, without the salt. Matt, if you happen to have access to any post-2003(ish) British texts (e.g. Martindale,
BNF, British Pharmacopoeia) they'll list the INNs (though sometimes BNF lists INNMs).
Techelf 05:23, 24 Dec 2004 (UTC)